EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ness, G. C.
Right arrow Articles by Chambers, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ness, G. C.
Right arrow Articles by Chambers, C. M.
Proceedings of the Society for Experimental Biology and Medicine 224:8-19 (2000)
© 2000 Society for Experimental Biology and Medicine


Review Article

Feedback and Hormonal Regulation of Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase: The Concept of Cholesterol Buffering Capacity

Gene C. Ness1, and Christopher M. Chambers


Department of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, Tampa, Florida 33612

Regulation of the expression of hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by the major end product of the biosynthetic pathway, cholesterol, and by various hormones is critical to maintaining constant serum and tissue cholesterol levels in the face of an ever-changing external environment. The ability to downregulate this enzyme provides a means to buffer the body against the serum cholesterol–raising action of dietary cholesterol. The higher the basal expression of hepatic HMG-CoA reductase, the greater the "cholesterol buffering capacity" and the greater the resistance to dietary cholesterol. This review focuses on the mechanisms of feedback and hormonal regulation of HMG-CoA reductase in intact animals rather than in cultured cells and presents the evidence that leads to the proposal that regulation of hepatic HMG-CoA reductase acts as a cholesterol buffer. Recent studies with animals have shown that feedback regulation of hepatic HMG-CoA reductase occurs at the level of translation in addition to transcription. The translational efficiency of HMG-CoA reductase mRNA is diminished through the action of dietary cholesterol. Oxylanosterols appear to be involved in this translational regulation. Feedback regulation by dietary cholesterol does not appear to involve changes in the state of phosphorylation of hepatic HMG-CoA reductase or in the rate of degradation of this enzyme. Several hormones act to alter the expression of hepatic HMG-CoA reductase in animals. These include insulin, glucagon, glucocorticoids, thyroid hormone and estrogen. Insulin stimulates HMG-CoA reductase activity likely by increasing the rate of transcription, whereas glucagon acts by opposing this effect. Hepatic HMG-CoA reductase activity undergoes a significant diurnal variation due to changes in the level of immunoreactive protein primarily mediated by changes in insulin and glucagon levels. Thyroid hormone increases hepatic HMG-CoA reductase levels by acting to increase both transcription and stability of the mRNA. Glucocorticoids act to decrease hepatic HMG-CoA reductase expression by destabilizing reductase mRNA. Estrogen acts to increase hepatic HMG-CoA reductase activity primarily by stabilizing the mRNA. Deficiencies in those hormones that act to increase hepatic HMG-CoA reductase gene expression lead to elevations in serum cholesterol levels. High basal expression of hepatic HMG-CoA reductase, whether due to genetic or hormonal factors, appears to result in greater cholesterol buffering capacity and thus increased resistance to dietary cholesterol.




This article has been cited by other articles:


Home page
J DAIRY SCIHome page
H. A. van Dorland, S. Richter, I. Morel, M. G. Doherr, N. Castro, and R. M. Bruckmaier
Variation in hepatic regulation of metabolism during the dry period and in early lactation in dairy cows
J Dairy Sci, May 1, 2009; 92(5): 1924 - 1940.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
W. R. Lagor, R. Heller, E. D. De Groh, and G. C. Ness
Functional Analysis of the Hepatic HMG-CoA Reductase Promoter by In Vivo Electroporation
Experimental Biology and Medicine, March 1, 2007; 232(3): 353 - 361.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
W. O. Ward, D. A. Delker, S. D. Hester, S.-F. Thai, D. C. Wolf, J. W. Allen, and S. Nesnow
Transcriptional Profiles in Liver from Mice Treated with Hepatotumorigenic and Nonhepatotumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil
Toxicol Pathol, December 1, 2006; 34(7): 863 - 878.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. C. Ness, R. C. Holland, and D. Lopez
Selective Compensatory Induction of Hepatic HMG-CoA Reductase in Response to Inhibition of Cholesterol Absorption.
Experimental Biology and Medicine, May 1, 2006; 231(5): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Hashimoto, R. N. Cohen, M. Yamada, K. R. Markan, T. Monden, T. Satoh, M. Mori, and F. E. Wondisford
Cross-talk between Thyroid Hormone Receptor and Liver X Receptor Regulatory Pathways Is Revealed in a Thyroid Hormone Resistance Mouse Model
J. Biol. Chem., January 6, 2006; 281(1): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. R. Lagor, E. D. de Groh, and G. C. Ness
Diabetes Alters the Occupancy of the Hepatic 3-Hydroxy-3-methylglutaryl-CoA Reductase Promoter
J. Biol. Chem., November 4, 2005; 280(44): 36601 - 36608.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Johansson, M. Rudling, T. S. Scanlan, T. Lundasen, P. Webb, J. Baxter, B. Angelin, and P. Parini
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice
PNAS, July 19, 2005; 102(29): 10297 - 10302.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. B. Hapon, S. M. Varas, G. A. Jahn, and M. S. Gimenez
Effects of hypothyroidism on mammary and liver lipid metabolism in virgin and late-pregnant rats
J. Lipid Res., June 1, 2005; 46(6): 1320 - 1330.
[Abstract] [Full Text] [PDF]


Home page
DNA ResHome page
K. Oishi, N. Amagai, H. Shirai, K. Kadota, N. Ohkura, and N. Ishida
Genome-wide Expression Analysis Reveals 100 Adrenal Gland-dependent Circadian Genes in the Mouse Liver
DNA Res, January 1, 2005; 12(3): 191 - 202.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. C. Ness and K. R. Gertz
Increased Sensitivity to Dietary Cholesterol in Diabetic and Hypothyroid Rats Associated with Low Levels of Hepatic HMG-CoA Reductase Expression
Experimental Biology and Medicine, May 1, 2004; 229(5): 407 - 411.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. C. Ness and K. R. Gertz
Hepatic HMG-CoA Reductase Expression and Resistance to Dietary Cholesterol
Experimental Biology and Medicine, May 1, 2004; 229(5): 412 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. Kisilevsky and S. P. Tam
Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1
J. Lipid Res., December 1, 2003; 44(12): 2257 - 2269.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Xu, L. Lecanu, Z. Han, Z. Yao, J. Greeson, and V. Papadopoulos
Inhibition of Adrenal Cortical Steroid Formation by Procaine Is Mediated by Reduction of the cAMP-Induced 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Messenger Ribonucleic Acid Levels
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1148 - 1157.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. W. Burgess, J. Boucher, T. A-M. Neville, P. Rouillard, C. Stamler, S. Zachariah, and D. L. Sparks
Phosphatidylinositol promotes cholesterol transport and excretion
J. Lipid Res., July 1, 2003; 44(7): 1355 - 1363.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H.-J. Gober, M. Kistowska, L. Angman, P. Jeno, L. Mori, and G. De Libero
Human T Cell Receptor {gamma}{delta} Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells
J. Exp. Med., January 20, 2003; 197(2): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. M. Cazita, J. A. Berti, C. Aoki, M. Gidlund, L. M. Harada, V. S. Nunes, E. C. R. Quintao, and H. C. F. Oliveira
Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice
J. Lipid Res., January 1, 2003; 44(1): 33 - 40.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. Liu and Y.-Y. Yeh
S-Alk(en)yl Cysteines of Garlic Inhibit Cholesterol Synthesis by Deactivating HMG-CoA Reductase in Cultured Rat Hepatocytes
J. Nutr., June 1, 2002; 132(6): 1129 - 1134.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. F. Tacer, T. B. Haugen, M. Baltsen, N. Debeljak, and D. Rozman
Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis-activating sterol (T-MAS)
J. Lipid Res., January 1, 2002; 43(1): 82 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. L. Bakker, J. C. ter Maaten, C. Popp-Snijders, J. P. J. Slaets, R. J. Heine, and R. O. B. Gans
The Relationship between Thyrotropin and Low Density Lipoprotein Cholesterol Is Modified by Insulin Sensitivity in Healthy Euthyroid Subjects
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1206 - 1211.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Experimental Biology and Medicine.